SR One Capital Management’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-272,885
| Closed | -$4.03M | – | 6 |
|
|
2023
Q3 | $4.03M | Hold |
272,885
| – | – | 2.06% | 5 |
|
|
2023
Q2 | $5.59M | Hold |
272,885
| – | – | 2.41% | 5 |
|
|
2023
Q1 | $2.39M | Hold |
272,885
| – | – | 0.89% | 6 |
|
|
2022
Q4 | $2.93M | Hold |
272,885
| – | – | 1.07% | 5 |
|
|
2022
Q3 | $3.89M | Hold |
272,885
| – | – | 1.78% | 4 |
|
|
2022
Q2 | $9.69M | Hold |
272,885
| – | – | 4.74% | 4 |
|
|
2022
Q1 | $27.4M | Hold |
272,885
| – | – | 14.01% | 3 |
|
|
2021
Q4 | $56.5M | Buy |
+272,885
| New | +$56.5M | 31.92% | 2 |
|